扫码登录小狗阅读
-
组织工程化的癌症转移用于癌症疫苗以改善癌症免疫治疗
Tissue engineered cancer metastases as cancer vaccine to improve cancer immunotherapy
From：Acta Biomater Date：2022-11-01
IF：10.6 类型：基础
Read：87 Author：Nikhila Reddy Sultanpuram
-
基于外泌体的纳米药物靶向炎症通路治疗癌症：现状和未来展望
Exosome-based nanomedicine for cancer treatment by targeting inflammatory pathways: Current status and future perspectives
From：Semin Cancer Biol Date：2022-11-01
IF：17.0 类型：综述
Read：34 Author：Mohammad Azam Ansari
-
用与上转换纳米粒子光交连结合的抗EGFR亲和体进行酶催化前体药物治疗
Enzyme Prodrug Therapy with Photo-Cross Linkable Anti-EGFR Affibodies Conjugated to Upconverting Nanoparticles
From：ACS Nano Date：2022-09-21
IF：18.0 类型：基础
Read：45 Author：Shambojit Roy
-
基于纳米颗粒的卵泡抑素信使 RNA 疗法用于重编程转移性卵巢癌和改善癌症相关恶病质
Nanoparticle-Based Follistatin Messenger RNA Therapy for Reprogramming Metastatic Ovarian Cancer and Ameliorating Cancer-Associated Cachexia
From：Small Date：2022-09-13
IF：15.1 类型：基础
Read：25 Author：Tetiana Korzun
-
胆道癌精准医学研究
Precision Medicine in Biliary Tract Cancer
From：J Clin Oncol Date：2022-08-20
IF：50.7 类型：综述
Read：78 Author：Aaron J Scott
-
利用ZIF8纳米反应器进行超声激活、肿瘤特异性原位合成的化疗剂，用于精准癌症治疗
Ultrasound-Activated, Tumor-Specific In Situ Synthesis of a Chemotherapeutic Agent Using ZIF 8 Nanoreactors for Precision Cancer Therapy
From：ACS nano Date：2022-08-03
IF：18.0 类型：基础
Read：156 Author：Putry Yosefa Siboro
-
阿特珠单抗新辅助治疗不符合顺铂资格的膀胱肌浸润性尿路上皮癌患者的最终结果
Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder
From：Eur Urol Date：2022-08-01
IF：24.2 类型：临床
Read：66 Author：Bernadett Szabados
-
纳米粒子组合用于胰腺癌的精确基质调控和改善递送效果
Nanoparticle combination for precise stroma modulation and improved delivery for pancreatic cancer
From：J Control Release Date：2022-07-11
IF：11.4 类型：基础
Read：123 Author：Mubin Tarannum
-
神经内分泌前列腺癌的δ样配体3靶向放射免疫疗法
Delta-like ligand 3–targeted radioimmunotherapy for neuroendocrine prostate cancer
From：Proc Natl Acad Sci U S A Date：2022-07-05
IF：12.7 类型：基础
Read：74 Author：Korsen JA
-
儿童肿瘤学组试验AALL1231: 测试硼替佐米用于新诊断的T细胞急性淋巴细胞白血病和淋巴瘤的III期临床试验
Children’s Oncology Group TrialAALL1231: A Phase III Clinical Trial Testing Bortezomib in Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia and Lymphoma
From：J Clin Oncol Date：2022-07-01
IF：50.7 类型：临床
Read：28 Author：David T Teachey
-
用于癌症靶向治疗的具有不同癌症亲和力的糖纳米粒子的系统筛选和治疗评估
Systematic Screening and Therapeutic Evaluation of Glyconanoparticles with Differential Cancer Affinities for Targeted Cancer Therapy
From：Adv Mater Date：2022-07-01
IF：32.0 类型：基础
Read：87 Author：Chang-Hee Whang
-
利用合成的IL-9受体增强细胞过继治疗
Potentiating adoptive cell therapy using synthetic IL-9 receptors
From：nature Date：2022-07-01
IF：69.5 类型：基础
Read：80 Author：Anusha Kalbasi
-
外泌体在肿瘤进展和肿瘤微环境重塑中的新作用
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
From：J Hematol Oncol Date：2022-06-28
IF：23.1 类型：综述
Read：117 Author：Paskeh MDA
-
治疗肛门高鳞状上皮内病变可以预防肛门癌
Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer
From：N Engl J Med Date：2022-06-16
IF：176.0 类型：临床
Read：190 Author：JM Palefsky
-
利用耐高温、自组装、单酶纳米颗粒和吲哚-3-乙酸转化的天然产物的生物正交催化治疗实体瘤
Bioorthogonal Catalysis for Treatment of Solid Tumors Using Thermostable, Self-Assembling, Single Enzyme Nanoparticles and Natural Product Conversion with Indole-3-acetic Acid
From：ACS Nano Date：2022-06-02
IF：18.0 类型：基础
Read：109 Author：Sadeghi S
-
基于金属－多酚网络的免疫活性纳米粒子联合双极不可逆电穿孔技术用于有效的癌症免疫治疗
Combination of Metal-Phenolic Network-Based Immunoactive Nanoparticles and Bipolar Irreversible Electroporation for Effective Cancer Immunotherapy
From：Small Date：2022-06-01
IF：15.1 类型：基础
Read：138 Author：Han JH
-
Sotigalimab和/或nivolumab联合化疗治疗一线转移性胰腺癌：随机2期PRINCE试验的临床和免疫学分析
Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
From：Nat Med Date：2022-06-01
IF：87.2 类型：临床
Read：15 Author：Lacey J Padrón
-
瓜地西他滨（SGI-110）在外周T细胞淋巴瘤中的临床和基因组综合评价
Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma
From：Leukemia Date：2022-06-01
IF：12.8 类型：临床
Read：106 Author：Wong J
-
静息肿瘤细胞簇通过构筑免疫抑制微环境逃避T细胞攻击
Quiescent cancer cells resist T cell attack by forming an immunosuppressive niche
From：cell Date：2022-05-12
IF：66.8 类型：基础
Read：169 Author：Pilar Baldominos
-
增强蛋白酶调节的CAR-T细胞受体的安全性和有效性
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
From：Cell Date：2022-05-12
IF：66.8 类型：基础
Read：198 Author：Labanieh L
